542 related articles for article (PubMed ID: 19370720)
1. Patenting of human embryonic stem cells in Europe.
Treichel P
Biotechnol J; 2009 Apr; 4(4):462-4. PubMed ID: 19370720
[No Abstract] [Full Text] [Related]
2. Ethical questions to ponder in the European stem cell patent debate.
Curley D; Sharples A
J Biolaw Bus; 2006; 9(3):12-6. PubMed ID: 17152135
[TBL] [Abstract][Full Text] [Related]
3. Patents: patenting of stem cell related inventions in Europe.
Rutz B; Yeats S
Biotechnol J; 2006 Apr; 1(4):384-7. PubMed ID: 16892264
[No Abstract] [Full Text] [Related]
4. Patenting and ethics--a dubious connection.
Crespi RS
J Pat Trademark Off Soc; 2003 Jan; 85(1):31-47. PubMed ID: 15212036
[No Abstract] [Full Text] [Related]
5. Stem cells caught in morality clause.
Siva N
Nat Biotechnol; 2009 Feb; 27(2):109. PubMed ID: 19204675
[No Abstract] [Full Text] [Related]
6. Challenges to human embryonic stem cell patents.
Plomer A; Taymor KS; Scott CT
Cell Stem Cell; 2008 Jan; 2(1):13-7. PubMed ID: 18371416
[TBL] [Abstract][Full Text] [Related]
7. Delivering on the promise of human stem-cell research. What are the real barriers?
Little M; Hall W; Orlandi A
EMBO Rep; 2006 Dec; 7(12):1188-92. PubMed ID: 17139291
[No Abstract] [Full Text] [Related]
8. The attack of the clones: patent law and stem cell research.
Rimmer M
J Law Med; 2003 May; 10(4):488-505. PubMed ID: 12852321
[TBL] [Abstract][Full Text] [Related]
9. New guidance on the patentability of embryonic stem cell patents in Europe.
Fitt R
Nat Biotechnol; 2009 Apr; 27(4):338-9. PubMed ID: 19352367
[No Abstract] [Full Text] [Related]
10. Patenting human pluripotent cells: balancing commercial, academic and ethical interests.
Bahadur G; Morrison M
Hum Reprod; 2010 Jan; 25(1):14-21. PubMed ID: 19897856
[TBL] [Abstract][Full Text] [Related]
11. Patenting, morality and human embryonic stem cell science: bioethics and cultural politics in Europe.
Salter B
Regen Med; 2007 May; 2(3):301-11. PubMed ID: 17511566
[TBL] [Abstract][Full Text] [Related]
12. Patenting the obvious?
Check E
Nature; 2007 May; 447(7140):16-7. PubMed ID: 17476235
[No Abstract] [Full Text] [Related]
13. Europe halts decisions on stem-cell patents.
Schubert S
Nature; 2005 Jun; 435(7043):720-1. PubMed ID: 15944658
[No Abstract] [Full Text] [Related]
14. Ethico-legal issues in biomedicine patenting: a patent professional viewpoint.
Crespi RS
Sci Eng Ethics; 2005 Jan; 11(1):117-36. PubMed ID: 15727007
[TBL] [Abstract][Full Text] [Related]
15. European court bans embryonic stem cell patents.
Moran N
Nat Biotechnol; 2011 Dec; 29(12):1057-9. PubMed ID: 22158341
[No Abstract] [Full Text] [Related]
16. Companies balk at California's patent rules for stem cell research.
Keim B
Nat Med; 2007 Jan; 13(1):6. PubMed ID: 17206112
[No Abstract] [Full Text] [Related]
17. Patents on parts of the human body: salient issues under EC and WTO law.
Herdegen M
J World Intellect Prop; 2002 Mar; 5(2):145-55. PubMed ID: 15986546
[No Abstract] [Full Text] [Related]
18. Ethical aspects of patenting human genotypes according to EC Biotechnology Directive.
Spranger TM
IIC Int Rev Ind Prop Copyr Law; 2000 Jun; 31(4):373-80. PubMed ID: 12956125
[No Abstract] [Full Text] [Related]
19. Bioethical ambition, political opportunity and the European governance of patenting: the case of human embryonic stem cell science.
Salter B; Salter C
Soc Sci Med; 2013 Dec; 98():286-92. PubMed ID: 23312796
[TBL] [Abstract][Full Text] [Related]
20. Derivation of human embryonic stem cell lines from single cells of 4-cell stage embryos: be aware of the risks.
Feki A; Hovatta O; Jaconi M
Hum Reprod; 2008 Dec; 23(12):2874. PubMed ID: 18854403
[No Abstract] [Full Text] [Related]
[Next] [New Search]
